Lim Bryant David 4
4 · IDERA PHARMACEUTICALS, INC. · Filed Apr 4, 2022
Insider Transaction Report
Form 4
Lim Bryant David
SVP & General Counsel
Transactions
- Award
Stock Option (Right to Buy)
2022-04-01+41,500→ 41,500 totalExercise: $0.54Exp: 2032-04-01→ Common Stock (41,500 underlying)
Footnotes (1)
- [F1]The stock option award was granted under the Issuer's 2013 Stock Incentive Plan. The stock option will vest and become exercisable in full on January 24, 2026, with 25% vesting on January 24, 2023, and the remainder vesting in twelve equal quarterly installments over the remaining three years, subject to continued service with the Issuer.